Krepel, Noralie
Egtberts, Tommy
Touré-Cuq, Emma
Bouny, Pierre
Arns, Martijn
Article History
Received: 25 March 2021
Accepted: 20 September 2021
First Online: 28 September 2021
Declarations
:
: ETC and PB are employees of UrgoTech. MA is unpaid chairman of the Brainclinics Foundation, a minority shareholder in neuroCare Group (Munich, Germany), and a co-inventor on 4 patent applications related to EEG, neuromodulation and psychophysiology, but receives no royalties related to these patents; Research Institute Brainclinics received research funding from Brain Resource (Sydney, Australia), Urgotech (France) and neuroCare Group (Munich, Germany), and equipment support from Deymed, neuroConn and Magventure.
: This study pertained an open-labelled study and treatment was conducted as usual, therefore no ethical approval for this study was obtained. However, all subjects provided explicit written informed consent for their data to be used for research.
: All participants provided informed consent.
: All participants provided informed consent.